Stephen M. Dorton - 25 Oct 2022 Form 4 Insider Report for Enfusion, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Oct 2022, 21:17:25 UTC
Prior SEC filing
17 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Blake Nielsen, as Attorney-in-Fact
Filing notes and source

Key filing fact

Stephen M. Dorton filed Form 4 for Enfusion, Inc. on 27 Oct 2022.

Key facts

  • This page summarizes Stephen M. Dorton's Form 4 filing for Enfusion, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Oct 2022, 21:17.

Change

  • Previous filing in this sequence was filed on 17 Jun 2022.
  • Current net transaction value: -$137,722.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENFN transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+38,423
Change %
+21%
Price
$0.000000
Shares after
225,036
Date
25 Oct 2022
Ownership
Direct
Footnotes
F1
ENFN transaction

Class A Common Stock

Tax liability

Transaction value
$137,722
Shares
-10,355
Change %
-4.6%
Price
$13.30
Shares after
214,681
Date
25 Oct 2022
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").

Footnote F2

Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .